Zeke Capital Advisors LLC Takes $214,000 Position in Masimo (MASI)

Zeke Capital Advisors LLC bought a new stake in shares of Masimo (NASDAQ:MASI) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 2,428 shares of the medical equipment provider’s stock, valued at approximately $214,000.

A number of other institutional investors have also added to or reduced their stakes in MASI. Champlain Investment Partners LLC acquired a new position in Masimo during the 4th quarter valued at about $16,841,000. Schroder Investment Management Group lifted its position in Masimo by 38.4% during the 4th quarter. Schroder Investment Management Group now owns 468,020 shares of the medical equipment provider’s stock valued at $39,687,000 after purchasing an additional 129,905 shares during the period. American Century Companies Inc. lifted its position in Masimo by 23.1% during the 4th quarter. American Century Companies Inc. now owns 587,070 shares of the medical equipment provider’s stock valued at $49,784,000 after purchasing an additional 110,107 shares during the period. Victory Capital Management Inc. lifted its position in Masimo by 36.4% during the 4th quarter. Victory Capital Management Inc. now owns 410,400 shares of the medical equipment provider’s stock valued at $34,802,000 after purchasing an additional 109,470 shares during the period. Finally, Wells Fargo & Company MN lifted its position in Masimo by 60.8% during the 4th quarter. Wells Fargo & Company MN now owns 247,347 shares of the medical equipment provider’s stock valued at $20,974,000 after purchasing an additional 93,506 shares during the period. Institutional investors own 80.76% of the company’s stock.

A number of research analysts have issued reports on MASI shares. Zacks Investment Research downgraded shares of Masimo from a “buy” rating to a “hold” rating in a research report on Monday, May 7th. ValuEngine upgraded shares of Masimo from a “hold” rating to a “buy” rating in a research report on Monday, May 7th. BidaskClub upgraded shares of Masimo from a “buy” rating to a “strong-buy” rating in a research report on Tuesday. Barclays started coverage on shares of Masimo in a research report on Friday, March 9th. They set an “overweight” rating and a $97.00 target price on the stock. Finally, Piper Jaffray upped their target price on shares of Masimo to $94.00 and gave the company a “neutral” rating in a research report on Wednesday, May 2nd. Two research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $102.71.

Shares of NASDAQ:MASI opened at $98.35 on Friday. The company has a market capitalization of $5.06 billion, a P/E ratio of 40.14, a PEG ratio of 2.33 and a beta of 0.95. Masimo has a fifty-two week low of $97.83 and a fifty-two week high of $99.19.

Masimo (NASDAQ:MASI) last announced its quarterly earnings results on Wednesday, May 2nd. The medical equipment provider reported $0.75 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.06. The business had revenue of $212.90 million for the quarter, compared to the consensus estimate of $205.65 million. Masimo had a net margin of 15.99% and a return on equity of 23.14%. Masimo’s revenue for the quarter was up 8.3% on a year-over-year basis. During the same period last year, the company posted $0.57 EPS. research analysts predict that Masimo will post 2.88 earnings per share for the current fiscal year.

In related news, insider Jon Coleman sold 29,303 shares of the stock in a transaction that occurred on Thursday, March 29th. The shares were sold at an average price of $87.50, for a total value of $2,564,012.50. Following the sale, the insider now directly owns 20,504 shares in the company, valued at approximately $1,794,100. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Yongsam Lee sold 5,800 shares of the stock in a transaction that occurred on Friday, April 27th. The shares were sold at an average price of $90.58, for a total transaction of $525,364.00. Following the completion of the sale, the executive vice president now owns 73,975 shares in the company, valued at $6,700,655.50. The disclosure for this sale can be found here. Insiders sold a total of 122,303 shares of company stock worth $11,148,690 over the last quarter. 12.60% of the stock is currently owned by corporate insiders.

About Masimo

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo (NASDAQ:MASI).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.




Leave a Reply